高级检索
当前位置: 首页 > 详情页

Primary Diffuse Large B-Cell Lymphoma of the Female Urethra: A Case Report and Review of the Literature.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]The Second School of Clinical Medicine,Guangzhou University of Chinese Medicine, Guangzhou 510405, People’sRepublic of China [2]Department ofUrology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, People’sRepublic of China [3]The First School ofClinical Medicine, Guangzhou Universityof Chinese Medicine, Guangzhou 510405,People’s Republic of China [4]Department of Surgery, Guangdong Provincial Hospitalof Chinese Medicine, Guangzhou 510120,People’s Republic of China
出处:
ISSN:

摘要:
Primary urethral non-Hodgkin's lymphoma (NHL) is uncommon. This case study reports the case of a 52-year-old woman with a light red mass at the urethral orifice. Her clinical manifestations included frequent urination, urgency, dysuria, and occasionally blood in urine. The tumor was surgically removed, and the pathological and immunohistochemistry examination confirmed the presence of a diffuse large B-cell lymphoma (DLBCL). Examination using positron emission tomography/computed tomography (PET/CT) revealed multiple hypermetabolic lymph nodes next to the external iliac vessels and bilateral inguinal regions, and focal hypermetabolic lesions in the vulvar nodules (consistent with the changes caused by lymphoma infiltration). Eight cycles of chemotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (R-CHOP) were prescribed after surgery. Re-examination using PET/CT showed lack of hypermetabolic tumor recurrence signs, and the presence of multiple slightly large lymph nodes in the lateral iliac vessels and inguinal regions, but without significant lymph node metabolism increases. To date, only fifteen cases of primary diffuse large B-cell lymphoma of the urethra (including this one) have been reported in the literature. Therefore, we reviewed the etiology, clinical manifestations, diagnosis, differential diagnosis, treatment, and prognosis of DLBCL based on the existing literature to help characterize this rare disease. © 2020 Zeng et al.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 3 区 医学
小类 | 3 区 生物工程与应用微生物 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 生物工程与应用微生物 4 区 肿瘤学
JCR分区:
出版当年[2018]版:
Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q2 ONCOLOGY
最新[2023]版:
Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]The Second School of Clinical Medicine,Guangzhou University of Chinese Medicine, Guangzhou 510405, People’sRepublic of China
通讯作者:
通讯机构: [4]Department of Surgery, Guangdong Provincial Hospitalof Chinese Medicine, Guangzhou 510120,People’s Republic of China [*1]Department of Surgery, Guangdong Provincial Hospital of Chinese Medicine, 111 Dade Road, Guangzhou 510120, People’s Republic of China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号